OpenURL Connection Search

Select item for more details and to access through your institution.

IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo.
Published in:
Cancer Immunology, Immunotherapy, 2010, v. 59, n. 6, p. 805, doi. 10.1007/s00262-009-0802-8
By:
- Benatar, Tania;
- Cao, Ming Y.;
- Yoon Lee;
- Lightfoot, Jeff;
- Ningping Feng;
- Xiaoping Gu;
- Vivian Lee;
- Hongnan Jin;
- Ming Wang;
- Wright, Jim A.;
- Young, Aiping H.
Publication type:
Article
Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16–18 October 2008.
Published in:
2010
By:
- Maio, Michele;
- Nicolay, Hugues J. M.;
- Ascierto, Paolo A.;
- Belardelli, Filippo;
- Camerini, Roberto;
- Colombo, Mario P.;
- Queirolo, Paola;
- Ridolfi, Ruggero;
- Russo, Vincenzo;
- Fonsatti, Ester;
- Parmiani, Giorgio
Publication type:
Proceeding
Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicity.
Published in:
Cancer Immunology, Immunotherapy, 2010, v. 59, n. 6, p. 885, doi. 10.1007/s00262-009-0815-3
By:
- Hong Lin;
- de Stanchina, Elisa;
- Xi Kathy Zhou;
- Feng Hong;
- Seidman, Andrew;
- Fornier, Monica;
- Wei-Lie Xiao;
- Kennelly, Edward J.;
- Wesa, Kathleen;
- Cassileth, Barrie R.;
- Cunningham-Rundles, Susanna
Publication type:
Article
“Tumor immunology meets oncology IV”, 23rd and 24th May 2008 Martin Luther University Halle-Wittenberg, Halle, Germany.
Published in:
2010
By:
- Bukur, Juergen;
- Loeffler, Dennis;
- Massa, Chiara;
- Mueller, Lutz;
- Riemann, Dagmar;
- Schmoll, Hans-Joachim;
- Seliger, Barbara
Publication type:
Editorial
Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activity.
Published in:
Cancer Immunology, Immunotherapy, 2010, v. 59, n. 6, p. 875, doi. 10.1007/s00262-009-0813-5
By:
- Matsushita, Norimasa;
- Komine, Hiroshi;
- Grolleau-Julius, Annabelle;
- Pilon-Thomas, Shari;
- Mulé, James J.
Publication type:
Article
Combination of IL-21 and IL-15 enhances tumour-specific cytotoxicity and cytokine production of TCR-transduced primary T cells.
Published in:
Cancer Immunology, Immunotherapy, 2010, v. 59, n. 6, p. 921, doi. 10.1007/s00262-010-0818-0
By:
- Pouw, Nadine;
- Treffers-Westerlaken, Elike;
- Kraan, Jaco;
- Wittink, Floyd;
- ten Hgen, Timo;
- Verweij, Jaap;
- Debets, Reno
Publication type:
Article
Vaccination with TCL plus MHSP65 induces anti-lung cancer immunity in mice.
Published in:
Cancer Immunology, Immunotherapy, 2010, v. 59, n. 6, p. 899, doi. 10.1007/s00262-010-0816-2
By:
- Bohan Dong;
- Luguo Sun;
- Xiuli Wu;
- Peiyin Zhang;
- Li Wang;
- Hongfei Wei;
- Lei Zhou;
- Xiaoping Hu;
- Yongli Yu;
- Shucheng Hua;
- Liying Wang
Publication type:
Article
CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting.
Published in:
Cancer Immunology, Immunotherapy, 2010, v. 59, n. 6, p. 851, doi. 10.1007/s00262-009-0810-8
By:
- Norell, Håkan;
- Yi Zhang;
- McCracken, James;
- da Palma, Telma Martins;
- Lesher, Aaron;
- Yueying Liu;
- Roszkowski, Jeffrey J.;
- Temple, Anquanette;
- Callender, Glenda G.;
- Clay, Timothy;
- Orentas, Rimas;
- Guevara-Patiño, José;
- Nishimura, Michael I.
Publication type:
Article
Circulating tumour-derived microvesicles in plasma of gastric cancer patients.
Published in:
Cancer Immunology, Immunotherapy, 2010, v. 59, n. 6, p. 841, doi. 10.1007/s00262-009-0808-2
By:
- Baran, Jaroslaw;
- Baj-Krzyworzeka, Monika;
- Weglarczyk, Kazimierz;
- Szatanek, Rafal;
- Zembala, Maria;
- Barbasz, Jakub;
- Czupryna, Antoni;
- Szczepanik, Antoni;
- Zembala, Marek
Publication type:
Article
HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase.
Published in:
Cancer Immunology, Immunotherapy, 2010, v. 59, n. 6, p. 943, doi. 10.1007/s00262-010-0820-6
By:
- Olson, Brian M.;
- Frye, Thomas P.;
- Johnson, Laura E.;
- Fong, Lawrence;
- Knutson, Keith L.;
- Disis, Mary L.;
- McNeel, Douglas G.
Publication type:
Article
Acknowledgement.
Published in:
Cancer Immunology, Immunotherapy, 2010, v. 59, n. 6, p. 975, doi. 10.1007/s00262-010-0828-y
Publication type:
Article
Generation of a stable anti-human CD44v6 scFv and analysis of its cancer-targeting ability in vitro.
Published in:
Cancer Immunology, Immunotherapy, 2010, v. 59, n. 6, p. 933, doi. 10.1007/s00262-010-0819-z
By:
- Yinting Chen;
- Kaihong Huang;
- Xuexian Li;
- Xiangan Lin;
- Zhaohua Zhu;
- Ying Wu
Publication type:
Article
Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment.
Published in:
Cancer Immunology, Immunotherapy, 2010, v. 59, n. 6, p. 819, doi. 10.1007/s00262-009-0803-7
By:
- Gasparoto, Thaís Helena;
- de souza Malaspina, Tatiana Souza;
- Benevides, Luciana;
- de Melo Jr,., Edgard Jose Franco;
- Nogueira Costa, Maria Renata Sales;
- Damante, José Humberto;
- Valéio Ikoma, Maura Rosane;
- Garlet, Gustavo Pompermaier;
- Cavassani, Karen Angélica;
- de Silva, João Santana;
- Campanelli, Ana Paula
Publication type:
Article
The second cellular therapy of cancer symposium, 27–29 March 2009, Milan, Italy.
Published in:
2010
By:
- Bridgeman, John S.;
- Gilham, David E.;
- Hawkins, Robert E.;
- Cheadle, Eleanor J.
Publication type:
Proceeding
Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked.
Published in:
Cancer Immunology, Immunotherapy, 2010, v. 59, n. 6, p. 829, doi. 10.1007/s00262-009-0807-3
By:
- von Lilienfeld-Toal, Marie;
- Frank, Susanne;
- Leyendecker, Christiane;
- Feyler, Sylvia;
- Jarmin, Sarah;
- Morgan, Ruth;
- Glasmacher, Axel;
- Märten, Angela;
- Schmidt-Wolf, Ingo G. H.;
- Brossart, Peter;
- Cook, Gordon
Publication type:
Article
Clinical and immunological responses in metastatic melanoma patients vaccinated with a high-dose poly-epitope vaccine.
Published in:
Cancer Immunology, Immunotherapy, 2010, v. 59, n. 6, p. 863, doi. 10.1007/s00262-009-0811-7
By:
- Dangoor, Adam;
- Lorigan, Paul;
- Keilholz, Ulrich;
- Schadendorf, Dirk;
- Harris, Adrian;
- Ottensmeier, Christian;
- Smyth, John;
- Hoffmann, Klaus;
- Anderson, Richard;
- Cripps, Martin;
- Schneider, Joerg;
- Hawkins, Robert
Publication type:
Article
Foxp3+ cell infiltration and granzyme B+/Foxp3+ cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma.
Published in:
Cancer Immunology, Immunotherapy, 2010, v. 59, n. 6, p. 909, doi. 10.1007/s00262-010-0817-1
By:
- Pölcher, Martin;
- Braun, Michael;
- Friedrichs, Nicolaus;
- Rudlowski, Christian;
- Bercht, Eva;
- Fimmers, Rolf;
- Sauerwald, Axel;
- Keyver-Paik, Mignon-Denise;
- Kübler, Kirsten;
- B#x00FC;ttner, Reinhard;
- Kuhn, Walther C.;
- Hernando, Juan-José
Publication type:
Article

Found: 17

IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo.

Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16–18 October 2008.

Maitake beta-glucan promotes recovery of leukocytes and myeloid cell function in peripheral blood from paclitaxel hematotoxicity.

“Tumor immunology meets oncology IV”, 23rd and 24th May 2008 Martin Luther University Halle-Wittenberg, Halle, Germany.

Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activity.

Combination of IL-21 and IL-15 enhances tumour-specific cytotoxicity and cytokine production of TCR-transduced primary T cells.

Vaccination with TCL plus MHSP65 induces anti-lung cancer immunity in mice.

CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting.

Circulating tumour-derived microvesicles in plasma of gastric cancer patients.

HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase.

Acknowledgement.

Generation of a stable anti-human CD44v6 scFv and analysis of its cancer-targeting ability in vitro.

Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment.

The second cellular therapy of cancer symposium, 27–29 March 2009, Milan, Italy.

Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked.

Clinical and immunological responses in metastatic melanoma patients vaccinated with a high-dose poly-epitope vaccine.

Foxp3<sup>+</sup> cell infiltration and granzyme B<sup>+</sup>/Foxp3<sup>+</sup> cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma.